中文
ENGLISH
Home
About Us
News
Products
EHS Management
Recruitment
Contact Us
中文版
Search
Categories
Diabetes series
Canagliflozin and intermediates
Dapagliflozin and intermediates
Empagliflozin and intermediates
Sotagliflozin and intermediates
Ipragliflozin and intermediates
Ertugliflozin and intermediates
Repaglinide and intermediates
Sitagliptin and intermediates
Features intermediates
Rivaroxaban and intermediates
Tofacitinib and intermediates
Baricitinib
Crizotinib
Larotrectinib
Research project
Elagolix
Filgotinib
Baloxavir
Imeglimin
PF-04965842
Ritlecitinib
Upadacitinib
Iptacopan
Asciminb
Sotorasib
Custom production
Link:
Lian Chuang Biomedicine
Products
Product Name
CAS NO.
Detailes
Classification
Rivaroxaban
366789-02-8
Rivaroxaban and intermediates
(S)-(+)-GLYCIDYL PHTHALIMIDE
161596-47-0
4-(4-AMINOPHENYL)MORPHOLIN-3-ONE
438056-69-0
5-Chloro-2-thiophenecarboxylic acid
24065-33-6
2-[(2R)-2-Hydroxy-3-[[4-(3-oxo-4-morpholinyl)phenyl]amino]propyl]-1H-isoindole-1,3(2H)-dione
446292-07-5
(S)-2-((2-Oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)isoindoline-1,3-dione
446292-08-6
(S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl
898543-06-1
Tofacitinib citrate
540737-29-9
Tofacitinib and intermediates
4-Chloro-7-tosyl-7H-pyrrolo[2,3-d]pyrimidine
479633-63-1
4-chloro-7H-pyrrolo[2,3-d]pyriMidine
3680-69-1
First
Previous
1
2
Next
Last
2
Pages
14
Items
Copyright 2018 Anhui Senji Pharmaceutical Co. , Ltd. All rights reserved.
Admin